Impact Factor 2024

Search

Search articles for

Advanced filters

Published AfterYearMonthDay

Published BeforeYearMonthDay

By Author

By Section

Search Results

##search.searchResults.foundPlural##

Drug survival and reasons for discontinuation of the first course of biological therapy in 301 juvenile idiopathic arthritis patients

M. Romano, I. Pontikaki, M. Gattinara, I. Ardoino, C. Donati, P. Boracchi, P.L. Meroni, V. Gerloni

278-285

17-03-2014

https://doi.org/10.4081/reumatismo.2013.682

2713

PDF: 1395
New approved drugs for psoriatic arthritis

F.M. Perrotta, E. Lubrano

57-64

09-09-2016

https://doi.org/10.4081/reumatismo.2016.873

3201

PDF: 2243
Safety profile of drugs used in the treatment of osteoporosis: a systematical review of the literature

M. Varenna, F. Bertoldo, M. Di Monaco, A. Giusti, G. Martini, M. Rossini, On behalf of SIOMMMS, Endorsed by SIR

143-166

31-10-2013

https://doi.org/10.4081/reumatismo.2013.143

7182

PDF: 2626
The economic burden of musculoskeletal disorders on the Italian social security pension system estimated by a Monte Carlo simulation

S. Russo, T. T. Mariani, R. Migliorini, A. Marcellusi, F. S. Mennini

45-56

16-09-2015

https://doi.org/10.4081/reumatismo.2015.811

2312

PDF: 1132
Safety of rituximab in the routine treatment of rheumatoid arthritis in Italy in patients refractory to anti-TNFa drugs: results from the observational retrospective-prospective RUBINO study

L. Bazzichi, D. Biasi, E. Tinazzi, M. Muratore, R. Pellerito, R. Russo, M. Corsaro Santi, P. De Sandre, O. Epis, M. Granata, B. Kroegler, C. Meschini, F. Versace, C. Astolfi

224-232

06-11-2014

https://doi.org/10.4081/reumatismo.2014.748

2370

PDF: 1586
Intra-articular therapy with tumor necrosis factor-α antagonists: an update

S. Bello, C. Bonali, L. Serafino, C. Rotondo, N. Terlizzi, G. Lapadula

257-263

14-03-2014

https://doi.org/10.4081/reumatismo.2013.721

2615

PDF: 1252
Evidences of safety and tolerability of the zoledronic acid 5 mg yearly in the post-menopausal osteoporosis: the HORIZON project

L. Dalle Carbonare, F. Bertoldo, V. Lo Cascio

54-64

https://doi.org/10.4081/reumatismo.2009.54

1282

PDF: 1075
Influenza vaccination is safe and effective in patients suffering from fibromyalgia syndrome

J. N. Ablin, V. Aloush, A. Brill, M. Berman, M. Barzilai, D. Caspi, M. Mandelboim, D. Levartovsky, A. Polachek, Y. Wolman, D. Paran, M. Barkagan, O. Elkayam

57-61

16-09-2015

https://doi.org/10.4081/reumatismo.2015.823

2237

PDF: 1062
How much does an antiinflammatory treatment cost?

D. Gatti, O. Viapiana, G. Colombo, S. Adami

248-252

https://doi.org/10.4081/reumatismo.2010.248

1271

PDF: 686
Safety of lornoxicam in G-6-PDH deficiency

G. Perpignano, E. Cacace, C. Matulli, V. Ruggiero

45-47

https://doi.org/10.4081/reumatismo.2003.45

782

PDF: 576
Janus kinase inhibitors in rheumatoid arthritis-associated interstitial lung disease: where do we stand and what may be the future?

Beatrice Maranini, Roberta Foti, Moustapha Taha, Veronica Venturelli, Andrea Lo Monaco, Marcello Govoni

29-01-2025

https://doi.org/10.4081/reumatismo.2025.1754

1605

PDF: 202

SUPPLEMENTARY MATERIAL: 113
Anti-tumor necrosis factor α: originators versus biosimilars, comparison in clinical response assessment in a multicenter cohort of patients with inflammatory arthropathies

C. Gioia, A. Picchianti Diamanti, R. Perricone, M.S. Chimenti, A. Afeltra, L. Navarini, A. Migliore, U. Massafra, V. Bruzzese, P. Scolieri, C. Meschini, M. Paroli, R. Caccavale, P. Scapato, R. Scrivo, F. Conti, B. Laganà, M. Di Franco

19-12-2023

https://doi.org/10.4081/reumatismo.2023.1602

1897

PDF: 467
Italian Society of Rheumatology recommendations for the management of gout

M. Manara, A. Bortoluzzi, M. Favero, I. Prevete, C.A. Scirè, G. Bianchi, C. Borghi, M. A. Cimmino, G. M. D'Avola, G. Desideri, G. Di Giacinto, M. Govoni, W. Grassi, A. Lombardi, M. Marangella, M. Matucci Cerinic, G. Medea, R. Ramonda, A. Spadaro, L. Punzi, G. Minisola

4-21

28-03-2013

https://doi.org/10.4081/reumatismo.2013.4

5762

PDF: 1555
Real-life effectiveness of rituximab in different subsets of idiopathic inflammatory myopathies

Stefano Stano, Fabio Cacciapaglia, Laura Coladonato, Giuseppe Lopalco, Florenzo Iannone, Marco Fornaro

07-04-2025

https://doi.org/10.4081/reumatismo.2025.1817

1660

PDF: 14

SUPPLEMENTARY MATERIAL: 292
Anakinra, a recombinant human IL-1 receptor antagonist, in clinical practice. Outcome in 60 patients with severe rheumatoid arthritis

C. Botsios, P. Sfriso, A. Furlan, P. Ostuni, M. Biscaro, U. Fiocco, S. Todesco, L. Punzi

32-37

https://doi.org/10.4081/reumatismo.2007.32

1681

PDF: 784
Adherence to vaccination against SARS-CoV-2 and vaccine safety in patients with IgG4-related disease

Linda Mastromanno, Federico Giardina, Angelica Gattamelata, Serena Colafrancesco, Simona Truglia, Francesca Romana Spinelli, Edoardo Simoncelli, Bruno Lucchino, Fabrizio Conti, Roberta Priori

22-01-2025

https://doi.org/10.4081/reumatismo.2025.1744

1322

PDF: 86

SUPPLEMENTARY MATERIAL: 33
Anti-TNFα agents in elderly patients with rheumatoid arthritis: a study of a group of 105 over sixty five years old patients

M. Filippini, C. Bazzani, S. Zingarelli, T. Ziglioli, M. Nuzzo, M. Vianelli, C. Biasini Rebaioli, R. Cattaneo, R. Gorla

41-49

https://doi.org/10.4081/reumatismo.2008.41

1183

PDF: 815
The safety of interleukin-1 receptor antagonist (anakinra) in the treatment of rheumatoid arthritis

L. Riente

74-79

https://doi.org/10.4081/reumatismo.2004.1s.74

774

PDF: 912
Intra-articular therapy with infliximab in psoriatic arthritis: efficacy and safety in refractory monoarthritis

S. Bello, C. Bonali, L. Serafino, P. Di Giuseppe, A. Minosi, N. Terlizzi

46-50

https://doi.org/10.4081/reumatismo.2010.46

1117

PDF: 1331
BIOLOGIC THERAPY OF PSORIATIC ARTHRITIS

D.D. Gladman

85-87

https://doi.org/10.4081/reumatismo.2007.1s.85

648

PDF: 583
Efficacy and safety of Amtolmetin Guacyl in the symptomatic treatment of the osteoarthritis

G. Biasi, L. Moltoni, C. Acciai, S. Di Martino, R. Marcolongo

145-150

https://doi.org/10.4081/reumatismo.2001.145

1024

PDF: 727
Two-years therapy with bosentan of pulmonary arterial hypertension related to connective tissue diseases

H. Marotta, R. Montisci, F. Tiso, S. Pontarollo, M. Rizzo, F. Tona, S. Iliceto, F. Cozzi

299-303

https://doi.org/10.4081/reumatismo.2007.299

946

PDF: 755
Discrepancies between clinical and pathological findings seen at renal biopsy in rheumatological diseases

R. Deniz, N. Güner, Ş.A. Ekmen, İ.N. Mutlu, D.S. Özgür, B. Karaalioğlu, G. Akkuzu, F. Yıldırım, K. Kalkan, G. Güzelant-Özköse, B. İnce, M. Erdoğan, Y. Özlük, I. Kılıçaslan, C. Bes

18-09-2023

https://doi.org/10.4081/reumatismo.2023.1586

1380

PDF: 556
Tolerability, safety and efficacy of Iloprost infusion without peristaltic pump in systemic sclerosis

M. Arreghini, P. Prudente, W. Maglione, C. Arnoldi, S. Tosi, A. Marchesoni

140-144

https://doi.org/10.4081/reumatismo.2001.140

848

PDF: 1163
Biological therapy with TNF-inhibitors in pediatric rheumatology. Review of the litterature and personal experience

V. Gerloni, I. Pontikaki, M Gattinara, F. Fantini

244-261

https://doi.org/10.4081/reumatismo.2007.244

1327

PDF: 1142
Safety profile of 185 ultrasound-guided intra-articular injections for treatment of rheumatic diseases of the hip

A. Migliore, S. Tormenta, L.S. Martin Martin, C. Valente, U. Massafra, A. Latini, A. Alimonti

104-109

https://doi.org/10.4081/reumatismo.2004.104

1246

PDF: 1038
Safety of anti-TNFa biological drugs

F. Trotta, G. Valentini

34-39

https://doi.org/10.4081/reumatismo.2005.4s.34

1185

PDF: 1194
The role of anifrolumab in reshaping the treatment landscape of extra-renal systemic lupus erythematosus

Fulvia Ceccarelli, Matteo Piga, Alessandra Bortoluzzi, Laura Coladonato, Micaela Fredi, Daniele Mauro, Chiara Tani, Luca Iaccarino

23-07-2025

https://doi.org/10.4081/reumatismo.2025.1830

805

PDF: 140
Are biological drugs safe in pregnancy?

A. Calligaro, A. Hoxha, A. Ruffatti, L. Punzi

304-317

31-03-2015

https://doi.org/10.4081/reumatismo.2014.798

3846

PDF: 2465
Effectiveness and safety profile of tofacitinib and baricitinib in rheumatoid arthritis patients: results from a 24-month real-life prospective study in Southern-Italy

M. Tasso, N. Bertolini, E. Mostacciuolo, S. Passavanti, J.M.E. Luppino, A. Del Puente, R. Peluso, F. Santelli, R. Scarpa, L. Costa, F. Caso

29-12-2022

https://doi.org/10.4081/reumatismo.2022.1511

1956

PDF: 858
Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?

M. Rossini, O Viapiana, G. Orsolini, E. Fracassi, L. Idolazzi, D. Gatti, S. Adami, M. Govoni

285-303

31-03-2015

https://doi.org/10.4081/reumatismo.2014.799

2566

PDF: 2299
Infections in patients with rheumatoid arthritis receiving anti-cytokine therapy: biological mechanisms and clinical aspects

C. Botsios, P. Ostuni, P. Sfriso, A. Furlan, U. Fiocco, D. Sgarabotto, S. Todesco

224-235

https://doi.org/10.4081/reumatismo.2003.224

1154

PDF: 2600
Retention rate of abatacept in rheumatoid arthritis patients in a real-life setting: results from a monocentric cohort

E. Molteni, C. Pirone, F. Ceccarelli, C. Castellani, C. Alessandri, M. Di Franco, V. Riccieri, F.R. Spinelli, R. Priori, R. Scrivo, F. Conti

24-06-2024

https://doi.org/10.4081/reumatismo.2024.1608

1653

PDF: 583
The Italian Society for Rheumatology clinical practice guidelines for rheumatoid arthritis

S. Parisi, A. Bortoluzzi, G.D. Sebastiani, F. Conti, R. Caporali, N. Ughi, I. Prevete, A. Ariani, M. Manara, G. Carrara, C.A. Scirè

22-49

23-09-2019

https://doi.org/10.4081/reumatismo.2019.1202

8033

PDF: 2528
A rare case of symptomatic creatine kinase elevation in a patient with rheumatoid arthritis treated with baricitinib

F.M. Mariani, A. Alunno, F. Carubbi, C. Ferri

24-06-2024

https://doi.org/10.4081/reumatismo.2024.1620

1519

PDF: 521
TNFa inhibition in anti-Ro/SSA positive patients with rheumatoid arthritis: clinical and immunological effects

I. Cavazzana, F. Bobbio-Pallavicini, C. Bazzani, E. Bravi, S. Zingarelli, A. Ceribelli, R. Caporali, R. Cattaneo, F. Franceschini, C. Montecucco

275-282

https://doi.org/10.4081/reumatismo.2006.275

1067

PDF: 955
Analgesic dose range finding of lornoxicam compared to diclofenac. Crossover double blind study in rheumatoid arthritis

G.P. Pasero, O. Di Munno

238-242

https://doi.org/10.4081/reumatismo.2002.238

3904
IL-1Ra (recombinant human IL-1 receptor antagonist) in the treatment of rheumatoid arthritis: the efficacy

U. Fiocco, M. Vezzù, L. Cozzi, S. Todesco

62-73

https://doi.org/10.4081/reumatismo.2004.1s.62

1317

PDF: 1938
Intra-articular etanercept treatment for severe diffuse pigmented villonodular knee synovitis

U. Fiocco, P. Sfriso, F. Oliviero, F. Sovran, E. Scagliori, E. Pagnin, M. Vezzù, L. Cozzi, C. Botsios, R. Nardacchione, A. Di Maggio, L. Rubaltelli, C. Giacometti, F. Calabrese, S. Todesco

268-274

https://doi.org/10.4081/reumatismo.2006.268

1579

PDF: 2712
Baricitinib in polymyalgia rheumatica and giant cell arteritis: report of six cases

Dario Camellino, Christian Dejaco, Franco Martini, Renzo Cosso, Gerolamo Bianchi

28-10-2024

https://doi.org/10.4081/reumatismo.2024.1796

1708

PDF: 330
The treatment of recurrent uveitis with TNFα inhibitors

P.C.F. Falappone, F. Iannone, C. Scioscia, V. Grattagliano, M. Covelli, G. Lapadula

185-189

https://doi.org/10.4081/reumatismo.2004.185

1781

PDF: 2407
Efficacy and safety of two generic copies of nimesulide in patients with low back pain or knee osteoarthritis

K.V. Ilic, M. Sefik-Bukilica, S. Jankovic, N. Vujasinovic-Stupar

27-33

https://doi.org/10.4081/reumatismo.2009.27

1538

PDF: 1150
Safety of methotrexate in rheumatoid arthritis: a retrospective cohort study in clinical practice

G. La Montagna, R. Tirri, R. Vitiello, D. Malesci, R. Buono, G. Mennillo, G. Valentini

261-267

https://doi.org/10.4081/reumatismo.2006.261

1224

PDF: 724
Evaluation of tramadol/paracetamol 75 mg/650 mg combination therapy for early-stage knee osteoarthritis: a retrospective observational study

Alessandro Conforti, Cosimo Ruggiero, Nastasja Palombi, Filippo Messina, Marco Bonifacio, Linda Lucchetti, Marco Ruggiero, Giuseppe La Cava, Roberto Piazza, Mario Mangrella

23-07-2025

https://doi.org/10.4081/reumatismo.2025.1872

960

PDF: 126
Efficacy and safety of anti-TNF agents in the Lombardy rheumatoid arthritis network (LORHEN)

P. Sarzi- Puttini, M. Antivalle, A. Marchesoni, E.G. Favalli, R. Gorla, M. Filippini, R. Caporali, F. Bobbio-Pallavicini, C. Montecucco, F. Atzeni

290-295

https://doi.org/10.4081/reumatismo.2008.290

2098

PDF: 1091
The data project: a shared approach between stakeholders of the healthcare system in definition of a therapeutic algorithm for inflammatory arthritis

I. Pantano, D. Mauro, D. Simone, L. Costa, D. Capocotta, M. Raimondo, D. Birra, G. Cuomo, T. D'Errico, M. Ferrucci, F. Comentale, G. Italiano, P. Moscato, N. Pappone, R. Russo, S. Scarpato, R. Tirri, P. Buono, A. Postiglione, R. Guida, R. Scarpa, U. Trama, E. Tirri, F. Ciccia

21-03-2023

https://doi.org/10.4081/reumatismo.2022.1528

1088

PDF: 610
Percutaneous vertebroplasty as therapy of vertebral fractures: results in a series of osteoporotic patients

C.U. Manzini, L. Bernini, S. Vallone, F. Cavallari, C. Ferri

209-214

https://doi.org/10.4081/reumatismo.2007.209

920

PDF: 1053
Treatment of Wegener’s granulomatosis

V. Riccieri, G. Valesini

69-76

https://doi.org/10.4081/reumatismo.2004.69

1354

PDF: 5247
Current therapeutic strategies for HCV-associated cryoglobulinemia

F. Iannuzzella, G. Garini

163-173

https://doi.org/10.4081/reumatismo.2008.163

1053

PDF: 2055
Anti-TNFa treatment in patients with rheumatoid arthritis and anti-Ro/SSA antibodies

I. Cavazzana, F. Franceschini, E. Danieli, M. Frassi, M. Vianelli, R. Gorla, P. Airò, R. Cattaneo

267-272

https://doi.org/10.4081/reumatismo.2005.267

1084

PDF: 1732

1 - 50 of 56 items 1 2 > >>

© PAGEPress 2008-2025 • PAGEPress^® is a registered trademark property of PAGEPress srl, Italy • VAT: IT02125780185 • Privacy